A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
We should gene-sequence cave paintings to find out more about who made them
Standard archeological techniques can’t determine whether the prehistoric artists were hunter-gatherers or farmers. Analyzing the paintings’ surfaces with techniques from biology offers much more information about how they worked and when they lived.
A cell-killing strategy to slow aging passed its first test this year
Are tired-out cells what make people old? A new generation of drugs is designed to wipe them out.
More than 26 million people have taken an at-home ancestry test
The genetic genie is out of the bottle. And it’s not going back.